Federated Investors logo

Federated Investors

North America, Pennsylvania, United States, Pittsburgh

Description

Federated Investors Inc. (FII) is an investment manager firm offering equity, fixed income and money market products.

Investor Profile

Federated Investors has backed more than 11 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 9% of its total and boasts 5 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series D, Series E rounds (top funding stages).
  • Majority of deals are located in United States, Israel.
  • Strong thematic focus on Health Care, Biotechnology, Pharmaceutical.

Stage Focus

  • Series C (18%)
  • Series D (18%)
  • Series E (18%)
  • Private Equity (9%)
  • Post Ipo Equity (9%)
  • Series F (9%)
  • Series B (9%)
  • Series Unknown (9%)

Country Focus

  • United States (82%)
  • Israel (18%)

Industry Focus

  • Health Care
  • Biotechnology
  • Pharmaceutical
  • Therapeutics
  • Medical
  • Women's
  • Biopharma
  • Consumer Electronics
  • E-commerce
  • Retail
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Federated Investors frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 4
Domain Associates
North America, California, United States, San Diego
Co-Investments: 2
Channel Medical Partners
North America, Illinois, United States, Skokie
Co-Investments: 3
PC
North America, Connecticut, United States, Westport
Co-Investments: 2
Deerfield
North America, New York, United States, New York
Co-Investments: 2
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 4
U.S. Venture Partners
North America, California, United States, Menlo Park
Co-Investments: 4
TF
North America, California, United States, El Dorado Hills
Co-Investments: 3
Forward Ventures
North America, California, United States, San Diego
Co-Investments: 4
Adimab
North America, New Hampshire, United States, Lebanon
Co-Investments: 1

What are some of recent deals done by Federated Investors?

Invivyd

Waltham, Massachusetts, United States

Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

BiotechnologyPharmaceuticalTherapeutics
Series CApr 19, 2021
Amount Raised: $336,000,000
SteadyMed Therapeutics

Tel Aviv, Tel Aviv, Israel

SteadyMed is a media-device company developing injectable therapeutic drugs for pain relief, diabetes and other chronic conditions.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Post Ipo EquityJul 30, 2016
Amount Raised: $32,000,000
aTyr Pharma

San Diego, California, United States

aTyr Pharma is a biotherapeutics company that discovers and develops protein biologics for human therapeutics.

BiotechnologyPharmaceuticalTherapeutics
Series EMar 31, 2015
Amount Raised: $76,000,000
SteadyMed Therapeutics

Tel Aviv, Tel Aviv, Israel

SteadyMed is a media-device company developing injectable therapeutic drugs for pain relief, diabetes and other chronic conditions.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series UnknownFeb 3, 2015
Amount Raised: $12,200,000
Otonomy

San Diego, California, United States

Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.

BiopharmaBiotechnologyHealth Care
Series DApr 30, 2014
Amount Raised: $49,000,000
Sanarus Medical

Pleasanton, California, United States

Sanarus Medical develops and markets minimally invasive devices for the diagnosis and treatment of breast tumors.

Health CareMedicalWomen's
Series EFeb 20, 2007
Amount Raised: $15,000,000
Sanarus Medical

Pleasanton, California, United States

Sanarus Medical develops and markets minimally invasive devices for the diagnosis and treatment of breast tumors.

Health CareMedicalWomen's
Series DApr 13, 2005
Amount Raised: $23,000,000
Sanarus Medical

Pleasanton, California, United States

Sanarus Medical develops and markets minimally invasive devices for the diagnosis and treatment of breast tumors.

Health CareMedicalWomen's
Series CNov 13, 2003
Amount Raised: $19,120,000
Acadia Pharmaceuticals Inc.

San Diego, California, United States

Acadia Pharmaceuticals develops and commercializes small molecule drugs for the treatment of central nervous system disorders.

BiotechnologyHealth CarePharmaceutical
Series FMar 31, 2003
Amount Raised: $25,000,000
Sanarus Medical

Pleasanton, California, United States

Sanarus Medical develops and markets minimally invasive devices for the diagnosis and treatment of breast tumors.

Health CareMedicalWomen's
Series BJul 24, 2001
Amount Raised: $13,800,000